COLL
Collegium Pharmaceutical IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$1.14B
P/E Ratio
20.38
EPS
$1.73
Beta
0.77
52W High
$50.79
52W Low
$25.86
50-Day MA
$40.51
200-Day MA
$39.11
Dividend Yield
—
Profit Margin
8.05%
Forward P/E
4.29
PEG Ratio
0.00
About Collegium Pharmaceutical Inc
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and markets pain management medications. The company is headquartered in Stoughton, Massachusetts.
Fundamentals
| Revenue (TTM) | $780.57M |
| Gross Profit (TTM) | $690.58M |
| EBITDA | $419.16M |
| Operating Margin | 30.00% |
| Return on Equity | 23.70% |
| Return on Assets | 7.27% |
| Revenue/Share (TTM) | $24.62 |
| Book Value | $9.51 |
| Price-to-Book | 3.40 |
| Price-to-Sales (TTM) | 1.46 |
| EV/Revenue | 1.862 |
| EV/EBITDA | 3.63 |
| Quarterly Earnings Growth (YoY) | 31.50% |
| Quarterly Revenue Growth (YoY) | 12.90% |
| Shares Outstanding | $32.41M |
| Float | $29.68M |
| % Insiders | 0.94% |
| % Institutions | 121.06% |
Historical Volatility
HV 10-Day
31.61%
HV 20-Day
37.95%
HV 30-Day
40.36%
HV 60-Day
37.69%
HV Rank
58.3%
Volatility is currently contracting
Analyst Ratings
Consensus ($54.17 target)
2
Strong Buy3
Buy1
HoldData last updated: 4/10/2026